Early Phase 1 Stroke Trial, Recruiting NCT04829071 Sponsor: University of Southern California Condition: Stroke
Back to Stroke

Early Phase 1 Stroke Trial, Recruiting

NCT04829071
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a stroke on one side of the brain only
  • People whose stroke happened more than 6 months ago
  • People whose weakness or paralysis affects only one side of their body
  • People who are able to walk on their own, with or without a walking aid such as a cane or walker
  • People who are able to walk for 5 minutes without stopping
  • People who answer "no" to all health questions on a standard exercise readiness questionnaire called the PAR-Q+ (confirm with trial site)
  • People who are willing to complete all parts of the study

Who may not be able to join:

  • People whose stroke affected the brainstem or cerebellum (lower and back parts of the brain)
  • People who have difficulty speaking, understanding speech, or both as a result of their stroke
  • People who have a significant muscle, bone, or nervous system condition (unrelated to their stroke) that could affect movement or thinking assessments
  • People who have metal in their head (outside of the mouth), or any implanted device in the head or chest that would make an MRI scan unsafe
  • People with high blood pressure that is not well controlled (above 160/110 mmHg)
  • People who are currently receiving physical therapy
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who have significant memory or thinking difficulties, based on a standard cognitive test score below 20 out of 30 (confirm with trial site)
  • People who are not able to give their own informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Kristan Leech, PT, DPT, PhD, University of Southern California

Phone: (323) 442-1583

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
16 January 2023
Est. completion
14 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

step length asymmetry - change in performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov